Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS

Journal of Proteome Research

Volumn 12, Issue 6, 2013, Pages 2791-2804

  Zhu, Jianhui ^a   Nie, Song ^a   Wu, Jing ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CD24; frozen tissue; laser capture microdissection; LC MS MS; pancreatic cancer; proteome profiling; spectral count

Indexed keywords

CD24 ANTIGEN; CD59 ANTIGEN; CD70 ANTIGEN; CD74 ANTIGEN; CELL SURFACE MARKER; GROWTH FACTOR; TGFBI PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNO LASER CAPTURE MICRODISSECTION; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEOMICS; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY;

EID: 84879345818     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400139c     Document Type: Article

References (55)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009 CA Cancer J. Clin. 2009, 59 (4) 225-249
2. Lowery, M. A.; O'Reilly, E. M. Pancreatic cancer: the role of molecular markers in diagnosis and management Clin. Adv. Hematol. Oncol. 2011, 9 (12) 900-908
3. Turtoi, A.; Musmeci, D.; Wang, Y.; Dumont, B.; Somja, J.; Bevilacqua, G.; De Pauw, E.; Delvenne, P.; Castronovo, V. Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma J. Proteome Res. 2011, 10 (9) 4302-4313
4. Mahadevan, D.; Von Hoff, D. D. Tumor-stroma interactions in pancreatic ductal adenocarcinoma Mol. Cancer Ther. 2007, 6 (4) 1186-1197
5. Johann, D. J.; Rodriguez-Canales, J.; Mukherjee, S.; Prieto, D. A.; Hanson, J. C.; Emmert-Buck, M.; Blonder, J. Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry J. Proteome Res. 2009, 8 (5) 2310-2318
6. Espina, V.; Heiby, M.; Pierobon, M.; Liotta, L. A. Laser capture microdissection technology Expert Rev. Mol. Diagn. 2007, 7 (5) 647-657
7. Shekouh, A. R.; Thompson, C. C.; Prime, W.; Campbell, F.; Hamlett, J.; Herrington, C. S.; Lemoine, N. R.; Crnogorac-Jurcevic, T.; Buechler, M. W.; Friess, H.; Neoptolemos, J. P.; Pennington, S. R.; Costello, E. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma Proteomics 2003, 3 (10) 1988-2001
8. Naidoo, K.; Jones, R.; Dmitrovic, B.; Wijesuriya, N.; Kocher, H.; Hart, I. R.; Crnogorac-Jurcevic, T. Proteome of formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma and lymph node metastases J. Pathol. 2012, 226 (5) 756-763
9. Liu, Y.; Wu, J.; Yan, G.; Hou, R.; Zhuang, D.; Chen, L.; Pang, Q.; Zhu, J. Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry Proteome Sci. 2010, 8, 2
10. Li, C.; Heidt, D. G.; Dalerba, P.; Burant, C. F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M. F.; Simeone, D. M. Identification of pancreatic cancer stem cells Cancer Res. 2007, 67 (3) 1030-1037
11. Kitaura, Y.; Chikazawa, N.; Tasaka, T.; Nakano, K.; Tanaka, M.; Onishi, H.; Katano, M. Transforming growth factor beta1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression Pancreas 2011, 40 (7) 1034-1042
12. Baumann, P.; Cremers, N.; Kroese, F.; Orend, G.; Chiquet-Ehrismann, R.; Uede, T.; Yagita, H.; Sleeman, J. P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis Cancer Res. 2005, 65 (23) 10783-10793
13. Ikenaga, N.; Ohuchida, K.; Mizumoto, K.; Yu, J.; Kayashima, T.; Hayashi, A.; Nakata, K.; Tanaka, M. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas Hum. Pathol. 2010, 41 (10) 1466-1474
14. Wisniewski, J. R.; Ostasiewicz, P.; Mann, M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers J. Proteome Res. 2011, 10 (7) 3040-3049
15. Michalski, A.; Damoc, E.; Lange, O.; Denisov, E.; Nolting, D.; Muller, M.; Viner, R.; Schwartz, J.; Remes, P.; Belford, M.; Dunyach, J. J.; Cox, J.; Horning, S.; Mann, M.; Makarov, A. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes Mol. Cell. Proteomics 2012, 11 (3) O111 013698
16. Liu, H.; Sadygov, R. G.; Yates, J. R., 3rd A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-4201
17. Colinge, J.; Chiappe, D.; Lagache, S.; Moniatte, M.; Bougueleret, L. Differential proteomics via probabilistic peptide identification scores Anal. Chem. 2005, 77 (2) 596-606
18. Philip, P. A.; Mooney, M.; Jaffe, D.; Eckhardt, G.; Moore, M.; Meropol, N.; Emens, L.; O'Reilly, E.; Korc, M.; Ellis, L.; Benedetti, J.; Rothenberg, M.; Willett, C.; Tempero, M.; Lowy, A.; Abbruzzese, J.; Simeone, D.; Hingorani, S.; Berlin, J.; Tepper, J. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment J. Clin. Oncol. 2009, 27 (33) 5660-5669
19. Immervoll, H.; Hoem, D.; Steffensen, O. J.; Miletic, H.; Molven, A. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers J. Histochem. Cytochem. 2011, 59 (4) 441-455
20. Zhu, J.; He, J.; Liu, Y.; Simeone, D. M.; Lubman, D. M. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray J. Proteome Res. 2012, 11 (4) 2272-2281
21. Mouledous, L.; Hunt, S.; Harcourt, R.; Harry, J. L.; Williams, K. L.; Gutstein, H. B. Proteomic analysis of immunostained, laser-capture microdissected brain samples Electrophoresis 2003, 24 (1-2) 296-302
22. Kay, R.; Rosten, P. M.; Humphries, R. K. CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor J. Immunol. 1991, 147 (4) 1412-1416
23. Al-Shahrour, F.; Minguez, P.; Tarraga, J.; Medina, I.; Alloza, E.; Montaner, D.; Dopazo, J. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments Nucleic Acids Res. 2007, 35 (Web Server issue) W91-96
24. Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis Nat. Methods 2009, 6 (5) 359-362
25. Dong, M. Q.; Venable, J. D.; Au, N.; Xu, T.; Park, S. K.; Cociorva, D.; Johnson, J. R.; Dillin, A.; Yates, J. R., 3rd Quantitative mass spectrometry identifies insulin signaling targets in C. elegans Science 2007, 317 (5838) 660-663
26. Chen, R.; Pan, S.; Duan, X.; Nelson, B. H.; Sahota, R. A.; de Rham, S.; Kozarek, R. A.; McIntosh, M.; Brentnall, T. A. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia Mol. Cancer 2010, 9, 149
27. Thompson, C. C.; Ashcroft, F. J.; Patel, S.; Saraga, G.; Vimalachandran, D.; Prime, W.; Campbell, F.; Dodson, A.; Jenkins, R. E.; Lemoine, N. R.; Crnogorac-Jurcevic, T.; Yin, H. L.; Costello, E. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility Gut 2007, 56 (1) 95-106
28. Baril, P.; Gangeswaran, R.; Mahon, P. C.; Caulee, K.; Kocher, H. M.; Harada, T.; Zhu, M.; Kalthoff, H.; Crnogorac-Jurcevic, T.; Lemoine, N. R. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway Oncogene 2007, 26 (14) 2082-2094
29. Sitek, B.; Sipos, B.; Alkatout, I.; Poschmann, G.; Stephan, C.; Schulenborg, T.; Marcus, K.; Luttges, J.; Dittert, D. D.; Baretton, G.; Schmiegel, W.; Hahn, S. A.; Kloppel, G.; Meyer, H. E.; Stuhler, K. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation J. Proteome Res. 2009, 8 (4) 1647-1656
30. Bai, X. F.; Ni, X. G.; Zhao, P.; Liu, S. M.; Wang, H. X.; Guo, B.; Zhou, L. P.; Liu, F.; Zhang, J. S.; Wang, K.; Xie, Y. Q.; Shao, Y. F.; Zhao, X. H. Overexpression of annexin 1 in pancreatic cancer and its clinical significance World J. Gastroenterol. 2004, 10 (10) 1466-1470
31. Proud, C. G. eIF2 and the control of cell physiology Semin. Cell Dev. Biol. 2005, 16 (1) 3-12
32. Clemens, M. J. Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins J. Cell. Mol. Med. 2001, 5 (3) 221-239
33. Boitano, A. E.; Wang, J.; Romeo, R.; Bouchez, L. C.; Parker, A. E.; Sutton, S. E.; Walker, J. R.; Flaveny, C. A.; Perdew, G. H.; Denison, M. S.; Schultz, P. G.; Cooke, M. P. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells Science 2010, 329 (5997) 1345-1348
34. Laplante, M.; Sabatini, D. M. mTOR signaling in growth control and disease Cell 2012, 149 (2) 274-293
35. Attwell, S.; Roskelley, C.; Dedhar, S. The integrin-linked kinase (ILK) suppresses anoikis Oncogene 2000, 19 (33) 3811-3815
36. Azios, N. G.; Krishnamoorthy, L.; Harris, M.; Cubano, L. A.; Cammer, M.; Dharmawardhane, S. F. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells Neoplasia 2007, 9 (2) 147-158
37. Karsdal, M. A.; Nielsen, M. J.; Sand, J. M.; Henriksen, K.; Genovese, F.; Bay-Jensen, A. C.; Victoria, S.; Adamkewicz, J. I.; Christiansen, C.; Leeming, D. J. Extracellular matrix remodeling: the common denominator in connective tissue diseases possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure Assay Drug Dev. Technol. 2013, 11 (2) 70-92
38. Crowe, D. L.; Shuler, C. F. Regulation of tumor cell invasion by extracellular matrix Histol. Histopathol. 1999, 14 (2) 665-671
39. Ryschich, E.; Khamidjanov, A.; Kerkadze, V.; Buchler, M. W.; Zoller, M.; Schmidt, J. Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer Pancreas 2009, 38 (7) 804-810
40. Gesierich, S.; Paret, C.; Hildebrand, D.; Weitz, J.; Zgraggen, K.; Schmitz-Winnenthal, F. H.; Horejsi, V.; Yoshie, O.; Herlyn, D.; Ashman, L. K.; Zoller, M. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility Clin. Cancer Res. 2005, 11 (8) 2840-2852
41. Meri, S.; Morgan, B. P.; Davies, A.; Daniels, R. H.; Olavesen, M. G.; Waldmann, H.; Lachmann, P. J. Human protectin (CD59), an 18000-20000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers Immunology 1990, 71 (1) 1-9
42. Schmitt, C. A.; Schwaeble, W.; Wittig, B. M.; Meyer zum Buschenfelde, K. H.; Dippold, W. G. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours Eur. J. Cancer 1999, 35 (1) 117-124
43. Goodwin, R. G.; Alderson, M. R.; Smith, C. A.; Armitage, R. J.; VandenBos, T.; Jerzy, R.; Tough, T. W.; Schoenborn, M. A.; Davis-Smith, T.; Hennen, K. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor Cell 1993, 73 (3) 447-456
44. Arens, R.; Tesselaar, K.; Baars, P. A.; van Schijndel, G. M.; Hendriks, J.; Pals, S. T.; Krimpenfort, P.; Borst, J.; van Oers, M. H.; van Lier, R. A. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion Immunity 2001, 15 (5) 801-812
45. Wischhusen, J.; Jung, G.; Radovanovic, I.; Beier, C.; Steinbach, J. P.; Rimner, A.; Huang, H.; Schulz, J. B.; Ohgaki, H.; Aguzzi, A.; Rammensee, H. G.; Weller, M. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma Cancer Res. 2002, 62 (9) 2592-2599
46. Diegmann, J.; Junker, K.; Loncarevic, I. F.; Michel, S.; Schimmel, B.; von Eggeling, F. Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes Neoplasia 2006, 8 (11) 933-938
47. Borghese, F.; Clanchy, F. I. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease Expert Opin. Ther. Targets 2011, 15 (3) 237-251
48. Ishigami, S.; Natsugoe, S.; Tokuda, K.; Nakajo, A.; Iwashige, H.; Aridome, K.; Hokita, S.; Aikou, T. Invariant chain expression in gastric cancer Cancer Lett. 2001, 168 (1) 87-91
49. Obsilova, V.; Silhan, J.; Boura, E.; Teisinger, J.; Obsil, T. 14-3-3 proteins: a family of versatile molecular regulators Physiol. Res. 2008, 57 (Suppl 3) S11-21
50. Chen, Y.; Knosel, T.; Kristiansen, G.; Pietas, A.; Garber, M. E.; Matsuhashi, S.; Ozaki, I.; Petersen, I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J. Pathol. 2003, 200 (5) 640-646
51. Mudduluru, G.; Medved, F.; Grobholz, R.; Jost, C.; Gruber, A.; Leupold, J. H.; Post, S.; Jansen, A.; Colburn, N. H.; Allgayer, H. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer Cancer 2007, 110 (8) 1697-1707
52. Schmid, T.; Jansen, A. P.; Baker, A. R.; Hegamyer, G.; Hagan, J. P.; Colburn, N. H. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion Cancer Res. 2008, 68 (5) 1254-1260
53. Jacob, J.; Bellach, J.; Grutzmann, R.; Alldinger, I.; Pilarsky, C.; Dietel, M.; Kristiansen, G. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades Pancreatology 2004, 4 (5) 454-460
54. Nagata, S.; Jin, Y. F.; Yoshizato, K.; Tomoeda, M.; Song, M.; Iizuka, N.; Kitamura, M.; Takahashi, H.; Eguchi, H.; Ohigashi, H.; Ishikawa, O.; Tomita, Y. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy Ann. Surg. Oncol. 2009, 16 (9) 2531-2538
55. Schneider, D.; Kleeff, J.; Berberat, P. O.; Zhu, Z.; Korc, M.; Friess, H.; Buchler, M. W. Induction and expression of betaig-h3 in pancreatic cancer cells Biochim. Biophys. Acta 2002, 1588 (1) 1-6